Skip to content

NLEN

Overview
Markets
Stocks
Movers
News
Watchlist
Calculator

Search stocks

/

Sourced stock news for investors.

NLEN

Markets

Overview
Markets
Stocks
Movers
Investment calculator

News & account

News
Watchlist
Settings
Paid Viewer
RSS feed

Legal

About KoersNu
Disclaimer
Privacy
Cookies
Terms

Contact

[email protected]

Financial information, not personal investment advice.

Prices are not real-time and may be delayed.

© 2026 KoersNu — All rights reserved.

Overview
Markets
Movers
News
Watchlist

Argenx news and analysis | KoersNu

Overview
Stocks
Argenx

Argenx (ARGX)

NasdaqUSDHealthcareAfter-hours

Overview
Price chart
Latest analyses
Profile

News about Argenx

Argenx reports positive Phase 2 results for FB102 and updates Phase 3 UNITY study

Read the analysis

Live price and chart

Live data comes from TradingView and may be delayed.

Latest analyses

Financial information, not personal investment advice.

Argenx · ARGX

Argenx reports positive Phase 2 results for FB102 and updates Phase 3 UNITY study

Argenx reported positive Phase 2 topline results for FB102 in celiac disease and issued an update on its Phase 3 UNITY trial in Sjögren's disease.

Oct 08, 2026

Illustrative photo

About Argenx

Argenx is listed on Nasdaq and belongs to the healthcare sector.

Sector: Healthcare
Industry: Biological Products, (No Diagnostic Substances)
Country: United States
Listing: ARGX · XNAS · USD

Similar stocks

Healthcare

Johnson & JohnsonJNJ · XNYS
AstraZenecaAZN · XLON
SanofiSAN · XPAR
PhilipsPHIA · XAMS
ModernaMRNA · XNAS